Skip to main content
Log in

Effects on the Pharmacokinetics and Pharmacodynamics in the Elderly of Coadministering Ramipril with Water, Apple Juice, and Applesauce

  • Note
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:821–8 (1993).

    Google Scholar 

  2. A. S. Hall, C. Winter, S. M. Bogie, A. F. Mackintosh, G. D. Murray, and S. G. Ball. The acute infarction ramipril efficacy (AIRE) study: rationale, design, organization, and outcome definitions. J. Cardiovasc. Pharmacol. 18(suppl 2):S105–S109 (1991).

    Google Scholar 

  3. V. Teetz, R. Geiger, R. Henning, and H. Urbach. Synthesis of a highly active angiotensin converting enzyme inhibitor: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (HOE 498). Arzneimittelforschung. 34(11)10B:1399–401 (1984).

    Google Scholar 

  4. H. Metzger, R. Maier, C. Sitter, and H. O. Stern. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (HOE 498)—a new and highly effective angiotensin-I converting enzyme inhibitor. Arzneimittelforschung. 34(11)10B:1402–6 (1984).

    Google Scholar 

  5. H. G. Eckert, M. J. Badian, D. Gantz, H-M. Kellner, and M. Volz. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-30-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (HOE 498) in rat, dog and man. Arzneimittelforschung. 34(11)10B:1435–1447 (1984).

    Google Scholar 

  6. P. Bunning. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (HOE 498 diacid). Comparison with captopril and enalaprilat. Arzneimittelforschung. 34(11)10B:1406–10 (1984).

    Google Scholar 

  7. M. K. Kottke, G. Stetsko, S. E. Rosenbaum, and C. T. Rhodes. Problems encountered by the elderly in the use of conventional dosage forms. J. Geriatr. Drug Ther. 5(2):77–92 (1990).

    Google Scholar 

  8. B. A. Rossi. Special considerations for drug therapy in the elderly. Pharm. Times. 55:72–3, 77–8 (1989).

    Google Scholar 

  9. D. J. Schuirmann. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokinet. Biopharm. 15:657–80 (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, ID., Hunt, T.L., Bradley, C.R. et al. Effects on the Pharmacokinetics and Pharmacodynamics in the Elderly of Coadministering Ramipril with Water, Apple Juice, and Applesauce. Pharm Res 13, 639–642 (1996). https://doi.org/10.1023/A:1016022827235

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016022827235

Navigation